Kerry G Oliver

Title: Kerry G Oliver: Innovator in Nucleic Acid Detection Technologies

Introduction

Kerry G Oliver is a notable inventor based in Austin, TX (US), recognized for his contributions to the field of nucleic acid detection technologies. With a total of 2 patents, Oliver has developed innovative methods that enhance the detection of specific genetic sequences and biological agents.

Latest Patents

Oliver's latest patents include a "System and method for inhibiting the decryption of a nucleic acid probe sequence used for the detection of a specific nucleic acid." This invention focuses on sequence-specific nucleic acid hybridization assays, which are essential for identifying genetic anomalies, mutations, and disease propensity. The technology allows for rapid determination of probe sequences, enabling the creation of reverse-engineered assays. Additionally, it provides methods to mask the identity of specific detection sequences, thereby improving the reliability of hybridization-based assays.

Another significant patent is for a "Multiple reporter read-out for bioassays." This method detects multiple reactive sites on an analyte using addressable microspheres and fluorescent reactants. It also includes techniques for determining allele zygosity and detecting single nucleotide polymorphisms (SNPs) in nucleic acid molecules. The invention offers a composition that enhances the detection capabilities in various biological assays.

Career Highlights

Throughout his career, Kerry G Oliver has worked with prominent companies such as Luminex Corporation and Radix Biosolutions, Ltd. His experience in these organizations has contributed to his expertise in developing advanced detection technologies.

Collaborations

Oliver has collaborated with notable professionals in his field, including James W Jacobson and Jennifer L Burroughs. These partnerships have fostered innovation and the advancement of nucleic acid detection methodologies.

Conclusion

Kerry G Oliver's work in nucleic acid detection technologies has significantly impacted the field of genetic research and diagnostics. His innovative patents and collaborations highlight his commitment to advancing scientific knowledge and improving detection methods.